Previous 10 | Next 10 |
BioLi f e Solutions (NASDAQ: BLFS) , which makes products that are used in the production of cell and gene therapies, is up 11.9% at 1:55 p.m. EDT after the company announced preliminary revenue for the second quarter and used the opportunity to raise $75 million. BioLife Solutions estimat...
BioLife Solutions (NASDAQ: BLFS ) -7.6% premarket on pricing 5.175M common shares at $14.50/share, for gross proceeds of ~$75M. More news on: BioLife Solutions, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
BOTHELL, Wash. , July 2, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the pricing of its public o...
BOTHELL, Wash. , July 1, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced estimated prelimi...
BOTHELL, Wash. , July 1, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced it intends to offer shares ...
BOTHELL, Wash. , May 18, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the promotion of Marcus Schulz...
We have BioLife ( BLFS ) in the SHU portfolio already for a year or so but grosso modo the shares haven't really done too much: We bought in the aftermath of the spike in 2018 so we're up a little, but not all that much. Yet there are obvious reasons we like the shares: The market for ce...
BioLife Solutions, Inc. (BLFS) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer Mike Rice - President & Chief Executive Officer Conference Call Participants Paul Knight - Janney Montgomery Suraj Ka...
Image source: The Motley Fool. Biolife Solutions Inc (NASDAQ: BLFS) Q1 2020 Earnings Call May 14, 2020 , 4:30 p.m. ET Operator Continue reading
BOTHELL, Wash. , May 14, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced financial results for the three ...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...